Disk diffusion quality control guidelines for NVP-PDF 713: A novel peptide deformylase inhibitor

Diagnostic Microbiology and Infectious Disease

Volumn 48, Issue 1, 2004, Pages 55-57

  Anderegg, Tamara R ^a   Jones, Ronald N ^a   Hall, G ^b,g   Fuhrmeister, A ^a,g   Knapp, C ^c,g   Rennie, R ^d,g   Wanger, A ^e,g   Limaye, A ^f,g  

^a JMI LABORATORIES   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Trek Diagnostic Systems   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY OF TEXAS   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g STRONG MEMORIAL HOSPITAL   (United States)

Author keywords

Disk diffusion; NVP PDF 713; Quality control

Indexed keywords

AMIDASE; ANTIINFECTIVE AGENT; LEVOFLOXACIN; N (5 FLUORO 1 OXIDO 2 PYRIDINYL) 1 [2 (N FORMYL N HYDROXYAMINOMETHYL)HEXANOYL]PROLINAMIDE; PEPTIDE DEFORMYLASE; PEPTIDE DEFORMYLASE INHIBITOR; VANCOMYCIN;

ARTICLE; BACTERIAL STRAIN; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; DIFFUSION; DRUG EFFECT; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GROWTH, DEVELOPMENT AND AGING; HAEMOPHILUS INFLUENZAE TYPE A; HUMAN; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; STANDARD; STANDARDIZATION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0842303166     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(03)00162-7     Document Type: Article

References (7)

1. Clements J.M., Beckett R.P., Brown A., et al. Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor. Antimicrob Agents Chemother. 45:2001;563-570.
2. Giglione C., Pierre M., Meinnel T. Peptide deformylase as a target for new generation, broad spectrum antimicrobial agents. Molec Microbiol. 36:2000;1197-1205.
3. Hackbarth C.J., Chen D.Z., Lewis J.G., et al. N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity. Antimicrob Agents Chemother. 46:2002;2752-2764.
4. Approved guideline M23-A2: Development of in vitro susceptibility testing criteria and quality control parameters. 2nd ed. 2001;. Wayne, PA: NCCLS.
5. Performance standards for antimicrobial disk susceptibility tests, 8 th ed. Approved standard M2-A8. 2003;. Wayne, PA: NCCLS.
6. Performance standards for antimicrobial susceptibility testing M100-S13. 2003;. Wayne, PA: NCCLS.
7. Wise R., Andrews J.M., Ashby J. In vitro activities of peptide deformylase inhibitors against Gram-positive pathogens. Antimicrob Agents Chemother. 46:2002;1117-1118.